France· FR:64463662
NEXAVAR 200 mg, comprimé pelliculé
A medicinal product containing tosilate de sorafénib, registered in France by BAYER AG (ALLEMAGNE), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- TOSILATE DE SORAFÉNIB
- Manufacturer
- BAYER AG (ALLEMAGNE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009376137294 plaquette(s) polypropylène aluminium de 28 comprimé(s)EUR 1.24
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tosilate de sorafénib in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaNEXAVARBayer AG, Leverkusen
- United StatesNexavarBayer HealthCare Pharmaceuticals Inc.
- NetherlandsFENESA 200 mg filmomhulde tablettenZentiva k.s.
- FinlandNexavarOrifarm Oy
- SpainNEXAVAR 200 mg COMPRIMIDOS RECUBIERTOS CON PELICULABayer Ag
- PolandNexavarBayer AG
- SwedenNexavar 200 mg Filmdragerad tablettBayer AG
- BelgiumNexavar 200 mgBayer
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Sorafenib, Sorafenib Bluefish
- Belgium · Sorafenib Eg, Sorafénib Eg
- Bulgaria · Сорафениб Зентива, Сорафениб Тева
- Cyprus · Rexanib
- Czechia · Sorafenib Pharmagen, Sorafenib Sandoz
- Germany · Sorafeb, Sorafenib Abz
- Denmark · Sorafenib "sandoz", Sorafenib Stada
- Estonia · Sorafenib Sandoz, Sorafenib Teva
- Spain · Sorafenib Dr. Reddys, Sorafenib Eugia
- Finland · Sorafenib Sandoz, Sorafenib Stada
- United Kingdom (Northern Ireland) · Sorafenib Sandoz, Sorafenib Teva
- Greece · Revamox, Sorafenib Bioars
- Croatia · Slam 200 Mg Tablete, Sorafenib Alpha-Medical
- Hungary · Fenesa, Renixola
- Iceland · Nexavar, Sorafenib
- Italy · Sorafenib Eg, Sorafenib Medac
- Liechtenstein · Nexavar, Sorafenib Accord
- Lithuania · Sorafenib Sandoz, Sorafenib Teva
- Luxembourg · Sorafenib Eg, Sorafenib Eurogenerics
- Latvia · Sorafenib Lv System, Sorafenib Sandoz
- Malta · Revamox, Sorafenib Pharos
- Netherlands · Fenesa, Sorafeb
- Norway · Nexavar, Sorafenib Accord
- Poland · Sorafenib G.L., Sorafenib Sandoz
- Portugal · Sorafenib, Sorafenib Eugia
- Romania · Sorafenib Dr. Reddy's, Sorafenib Sandoz
- Sweden · Sorafenib Bluefish, Sorafenib Sandoz
- Slovenia · Sorafenib Sandoz, Sorafenib Teva
- Slovakia · Sorafenib, Sorafenib Pharmagen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/05f6155c-39cd-4dc5-b71c-31280f0f8aa3 GET /v1/drugs/05f6155c-39cd-4dc5-b71c-31280f0f8aa3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "64463662",
"date_amm": "2006-07-19",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/06/342",
"substance": "TOSILATE DE SORAFÉNIB",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about tosilate de sorafénib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.